Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Genmab's world class discovery, development and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs. Our primary goal is to improve the lives of patients who are in urgent need of new treatment options. Learn more about Genmab

Three articles by Genmab scientists are featured in the August 2008 edition of Current Opinion in Immunology. Click here to view the articles (pages 426, 431 and 479).